Loading...
For HIV specialists, notable memories of 2011 will undoubtedly include the presentation and publication of the landmark HPTN 052 study, which proved, finally, that the divide between HIV treatment and prevention is a false one. The repercussions of this study are vast — both in the clinic, where patients almost universally acknowledge that these findings motivate them to want therapy, and in policy forums, where leaders now need to consider whether to recommend HIV treatment for all patients, regardless of CD4-cell count. In our 2011 Year in Review, we offer our perspective on this and other important themes in HIV clinical practice today.
HIV Treatment as Prevention — The Time Is Now
Antiretroviral Pre-Exposure Prophylaxis: New Hope and New …